Anticoagulation Strategies in Atrial Fibrillation

被引：4
作者：
Menezes, Arthur R. [1 ]
Artham, Surya [1 ]
Lavie, Carl J. [1 ,2 ]
Khatib, Sammy [1 ]
机构：
[1] Univ Queensland, Sch Med, Ochsner Clin Sch, Dept Cardiovasc Dis,John Ochsner Heart & Vasc Ins, New Orleans, LA USA
[2] Pennington Biomed Res Ctr, Dept Prevent Med, Baton Rouge, LA USA
来源：
REVIEWS IN CARDIOVASCULAR MEDICINE | 2012年 / 13卷 / 01期
关键词：
Atrial fibrillation; Stroke; Antithrombotic therapy; Warfarin; SHORT-TERM ANTICOAGULATION; DUAL-ANTIPLATELET THERAPY; STROKE PREVENTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ELECTRICAL CARDIOVERSION; ANTITHROMBOTIC THERAPY; RISK STRATIFICATION; PREDICTING STROKE; FACTOR XA; THROMBOEMBOLIC EVENTS;
D O I：
10.3909/ricm0616
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Atrial fibrillation (AF) is a major risk factor for stroke and systemic embolization, particularly in the elderly. Approximately 2.3 million adults in the United States have AF, and it is projected that this number will increase to approximately 5.6 million individuals by the year 2050, with over 50% aged 80 years or older. Vitamin K antagonists are currently the most widely accepted means of stroke prevention in patients with AF; unfortunately, this method of treatment is not a feasible option for many patients for numerous reasons. This article examines and compares the various newer therapeutic agents that have either been approved by the US Food and Drug Administration or are still in various stages of clinical testing, and provides an overview of established antithrombotic therapies. We also discuss the role of anticoagulation in the setting of cardioversion in patients with AF. (C) 2012 MedReviews(R), LLC
引用
收藏
页码：E1 / E13
页数：13
相关论文
共 82 条
[1]   Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation - Pooled analysis of SPORTIF III and V clinical trials [J].
Akins, Paul T. ;
Feldman, Harvey A. ;
Zoble, Robert G. ;
Newman, David ;
Spitzer, Stefan G. ;
Diener, Hans-Christoph ;
Albers, Gregory W. .
STROKE, 2007, 38 (03) :874-880
[2]  
[Anonymous], 2010, AM HEART J
[3]  
Benavente O, 1997, J NEUROL SCI, V153, P110
[4]  
Benavente O, 2000, COCHRANE DB SYST REV
[5]   Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: A retrospective analysis [J].
Berger, M ;
Schweitzer, P .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (12) :1545-+
[6]   Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease [J].
Berger, Peter B. ;
Bhatt, Deepak L. ;
Fuster, Valentin ;
Steg, P. Gabriel ;
Fox, Keith A. A. ;
Shao, Mingyuan ;
Brennan, Danielle M. ;
Hacke, Werner ;
Montalescot, Gilles ;
Steinhubl, Steven R. ;
Topol, Eric J. .
CIRCULATION, 2010, 121 (23) :2575-2583
[7]   A global view of atherothrombosis: Baseline characteristics in the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (CHARISMA) trial [J].
Bhatt, DL ;
Fox, KA ;
Hacke, W ;
Berger, PB ;
Black, HR ;
Boden, WE ;
Cacoub, P ;
Cohen, EA ;
Creager, MA ;
Easton, JD ;
Flather, MD ;
Haffner, SM ;
Hamm, CW ;
Hankey, GJ ;
Johnston, SC ;
Mak, KH ;
Mas, JL ;
Montalescot, G ;
Pearson, TA ;
Steg, G ;
Steinhubl, SR ;
Weber, MA ;
Booth, J ;
Topol, EJ .
AMERICAN HEART JOURNAL, 2005, 150 (03) :401.e1-401.e7
[8]   Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].
Bhatt, DL ;
Fox, KAA ;
Hacke, W ;
Berger, PB ;
Black, HR ;
Boden, WE ;
Cacoub, P ;
Cohen, EA ;
Creager, MA ;
Easton, JD ;
Flather, MD ;
Haffner, SM ;
Hamm, CW ;
Hankey, GJ ;
Johnston, SC ;
Mak, KH ;
Mas, JL ;
Montalescot, G ;
Pearson, TA ;
Steg, PG ;
Steinhubl, SR ;
Weber, MA ;
Brennan, DM ;
Fabry-Ribaudo, L ;
Booth, J ;
Topol, EJ ;
Frye, RL ;
Amarenco, P ;
Brass, LM ;
Buyse, M ;
Cohen, LS ;
DeMets, DL ;
Fuster, V ;
Hart, RG ;
Marler, JR ;
McCarthy, C ;
Schoemig, A ;
Lincoff, AM ;
Brener, SJ ;
Sila, CA ;
Albuquerque, A ;
Aroutiounov, G ;
Artemiev, D ;
Atkeson, BG ;
Bartel, T ;
Basart, DCG ;
Lima, AB ;
Belli, G ;
Bordalo e Sa, AL ;
Bosch, X .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717
[9]   EFFICACY OF ANTICOAGULANT THERAPY IN PREVENTING EMBOLISM RELATED TO DC ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION [J].
BJERKELUND, CJ ;
ORNING, OM .
AMERICAN JOURNAL OF CARDIOLOGY, 1969, 23 (02) :208-+
[10]   EXCLUSION OF ATRIAL THROMBUS BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY DOES NOT PRECLUDE EMBOLISM AFTER CARDIOVERSION OF ATRIAL-FIBRILLATION - A MULTICENTER STUDY [J].
BLACK, IW ;
FATKIN, D ;
SAGAR, KB ;
KHANDHERIA, BK ;
LEUNG, DY ;
GALLOWAY, JM ;
FENELEY, MP ;
WALSH, WF ;
GRIMM, RA ;
STOLLBERGER, C ;
VERHORST, PMJ ;
KLEIN, AL .
CIRCULATION, 1994, 89 (06) :2509-2513
123456789